Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Pasqal's Form F-4 registration statement declared effective by SEC on August 5, 2026 for proposed $300M business combination with Bleichroeder Acquisition Corp. II.
Callan JMB Inc. (NASDAQ: CJMB) formed Callan Power LLC, a wholly owned subsidiary focused on domestic manufacturing of critical electrical infrastructure.
Ascendis Pharma's COACH trial shows durable growth in children with achondroplasia using TransCon CNP and hGH combination therapy, with mean AGV at or above the 97th percentile.
Phase 1 data for MBX 4291, a GLP-1/GIP co-agonist prodrug for obesity, supports potential for once-monthly dosing with mean weight loss of 7% at eight weeks.
GoldHaven Resources Corp. has contracted Layne do Brasil Ltda. for an eight-hole, 1,650-metre Phase II drill program at the Copeçal West Target in Brazil.
